FORMULATION AND EVALUATION OF GLIMEPIRIDE PATCHES FOR TRANSDERMAL DRUG DELIVERY
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2016, Vol 5, Issue 6
Abstract
Transdermal drug delivery has been accepted as a potential non-invasive route of drug administration, with advantages of prolonged therapeutic action, less side effect, easy use and improved patient compliance. Glimepiride is an anti-diabetic drug with a shorter half life of ~5 hours, low bioavailability and extensive first pass metabolism due to these limitations required to maintain the therapeutic level it has chosen as transdermal drug delivery system.The present study was to formulate and evaluate transdermal drug delivery system of Glimepiride using polymers such as HPMC & Eudragit RS100 by solvent casting technique. Central composite design (CCD) was applied by using design-expert to optimize composition of HPMC and ERS100 for Transdermal Drug Delivery. The prepared formulations were evaluated for different physicochemical characteristics like Weight Variation, Folding Endurance, Flatness, pH of patches, % Moisture Content, % Moisture uptake, % Elongation, % Drug Content & % Drug Release. The drug release characteristics of the formulation were studied in-vitro by using semi-permeable membrane. The in-vitro drug release plot showed that the drug release followed zero order kinetics & Higuchi model, which was evidenced from the regression values. Based on the drug release and physicochemical values obtained from the formulation F3 is considered as an optimized formulation which shows higher percentage of drug release (97.33±0.26% at 24 hour) with diffusion mediated mechanism. Korsmeyer-Peppas exponential plots shows fairly linear add, it is well supported by their regression coefficient values & slope values (n) were more than 1 which suggest that drug was released by Super Case-II transport.
Authors and Affiliations
RAHUL SHIVAJIRAO SOLUNKE*| Research Scholar, PRIST University, Vallam, Thanjavur-613403. Tamilnadu, India, PRAVEEN D. CHAUDHARI| PES’S Modern College of Pharmacy, Nigdi, Pune-411044. Maharashtra, India.
Keywords
Related Articles
- EP ID EP3793
- DOI -
- Views 526
- Downloads 31
ESBL PRODUCING ENTEROBACTERIACEAE ISOLATES – PREVALANCE AND THEIR SUSCEPTIBILITY PATTERNS
Background: Antimicrobial resistance seen among many Enterobacteriaceae isolates, especially those expressing extended spectrum beta lactamase (ESBL) enzymes are on the rise. This has limited our treatment options and...
FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS OF MEFENAMIC ACID USING HYDROPHOBIC POLYMERS
Mefenamic acid is a non-steroidal anti-inflammatory drug used to treat pain, including menstrual pain. It has a dose of 250 mg 4 times daily. It has a very short half life of 2 hours and thus controlling the release wou...
RP-UFLC-DAD METHOD FOR THE DETERMINATION OF PIPERACILLIN AND TAZOBACTAM SODIUM IN BULK AND MARKETED FORMULATIONS
Aim: To develop a simple, sensitive, rapid, robust and reproducible method for the simultaneous determination of piperacillin and tazobactam sodium using ultra fast chromatographic method (UFLC). Materials and Methods: T...
H1N1 AND MOLECULAR DIAGNOSIS- RAPID AND EASE IN VIRAL AND DISEASE MONITORING
Influenza a viruses are medically significant pathogens responsible for higher mortality and morbidity throughoutthe world. Swine influenza known to be caused by influenza A subtypes H1N1, H1N2, H2N3,H3N1, and H3N2, is a...
SEROPREVALENCE OF PARVOVIRUS B19 AMONG SUDANESE PATIENTS WITH SYSTEMIC LUPUS ERYTHMATOSUS
Background Parvovirus B19 is a human pathogen that may result in spectrum of clinical features range from subclinical infection to potentially fatal effects. To the best of our knowledge, there was no study published in...